2fcg: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="2fcg" size="450" color="white" frame="true" align="right" spinBox="true" caption="2fcg" /> '''Solution structure of the C-terminal fragme...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2fcg.gif|left|200px]]<br />
[[Image:2fcg.gif|left|200px]]<br /><applet load="2fcg" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="2fcg" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="2fcg" />
caption="2fcg" />
'''Solution structure of the C-terminal fragment of human LL-37'''<br />
'''Solution structure of the C-terminal fragment of human LL-37'''<br />


==Overview==
==Overview==
To understand the structure and activity relationship of human LL-37, a, series of peptide fragments was designed. The N-terminal fragment, LL-37(1-12), was not active, while the C-terminal fragment, LL-37(13-37), killed Escherichia coli, as well as drug-sensitive and drug-resistant, cancer cells. A 13-residue core antibacterial and anticancer peptide, corresponding to residues 17-29 of LL-37, was identified based on total, correlated spectroscopy by trimming nonessential regions (TOCSY-trim)., Because LL-37 acts on bacterial membranes, three-dimensional structures of, its fragments were determined in micelles by NMR, including structural, refinement by natural abundance 15N and 13C chemical shifts., Aromatic-aromatic interactions in the N-terminal fragment were proposed to, be essential for LL-37 aggregation. The LL-37 core peptide adopts a, similar structure in the micelles of SDS or dioctanoyl, phosphatidylglycerol. This structure is retained in the C-terminal, fragment LL-37(13-37) and very likely in intact LL-37 based on, peptide-aided signal assignments. The higher antibacterial activity of the, LL-37 core peptide than aurein 1.2 was attributed to additional cationic, residues. To achieve selective membrane targeting, D-amino acids were, incorporated into LL-37(17-32). While the D-peptide showed similar, antibacterial activity to the L-diastereomer, it lost toxicity to human, cells. Structural analysis revealed hydrophobic defects in the new, amphipathic structure of the D-peptide, leading to a much shorter, retention time on a reversed-phase HPLC column. It is proposed that, hydrophobic defects as a result of incoherent hydrophobic packing provide, a structural basis for the improvement in cell selectivity of the LL-37, fragment.
To understand the structure and activity relationship of human LL-37, a series of peptide fragments was designed. The N-terminal fragment, LL-37(1-12), was not active, while the C-terminal fragment, LL-37(13-37), killed Escherichia coli, as well as drug-sensitive and drug-resistant cancer cells. A 13-residue core antibacterial and anticancer peptide, corresponding to residues 17-29 of LL-37, was identified based on total correlated spectroscopy by trimming nonessential regions (TOCSY-trim). Because LL-37 acts on bacterial membranes, three-dimensional structures of its fragments were determined in micelles by NMR, including structural refinement by natural abundance 15N and 13C chemical shifts. Aromatic-aromatic interactions in the N-terminal fragment were proposed to be essential for LL-37 aggregation. The LL-37 core peptide adopts a similar structure in the micelles of SDS or dioctanoyl phosphatidylglycerol. This structure is retained in the C-terminal fragment LL-37(13-37) and very likely in intact LL-37 based on peptide-aided signal assignments. The higher antibacterial activity of the LL-37 core peptide than aurein 1.2 was attributed to additional cationic residues. To achieve selective membrane targeting, D-amino acids were incorporated into LL-37(17-32). While the D-peptide showed similar antibacterial activity to the L-diastereomer, it lost toxicity to human cells. Structural analysis revealed hydrophobic defects in the new amphipathic structure of the D-peptide, leading to a much shorter retention time on a reversed-phase HPLC column. It is proposed that hydrophobic defects as a result of incoherent hydrophobic packing provide a structural basis for the improvement in cell selectivity of the LL-37 fragment.


==About this Structure==
==About this Structure==
2FCG is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/ ]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2FCG OCA].  
2FCG is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/ ]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FCG OCA].  


==Reference==
==Reference==
Line 18: Line 17:
[[Category: ll-37; host defense peptide; antimicrobial peptide]]
[[Category: ll-37; host defense peptide; antimicrobial peptide]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 22:03:16 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:19:57 2008''